SENSORIUM
LIVE

Serial Number

99141812

Owner

Sensorium Therapeutics, Inc.

Attorney

John L. DuPre'

Filing Date

Apr 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SENSORIUM Trademark

Serial Number: 99141812

SENSORIUM is a trademark filed by Sensorium Therapeutics, Inc. on April 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Sensorium Therapeutics, Inc.

47 High St. #513
Medford, MA 02155

Entity Type: 03

Trademark Details

Filing Date

April 17, 2025

Registration Date

Not Registered

Goods & Services

Providing scientific and technological information, namely, results from medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; Providing scientific information, namely, results from pharmaceutical, biomedical and biological therapeutic research; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials; providing a website featuring research and development information in the therapeutics, pharmaceutical and biotechnology fields for treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; research and development of therapeutics

Providing information relating to the diagnostic, prophylactic, and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human and veterinary neurological, neurodegenerative and other central nervous system diseases, disorders, and conditions

Pharmaceutical preparations for human use for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders; pharmaceutical preparations for medical and therapeutic purposes for the treatment of diseases of the central nervous system, psychiatric, neurological, and neurodegenerative disorders

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 22, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 22, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 17, 2025 MAFR
NEW APPLICATION ENTERED
Apr 17, 2025 NWAP